Business · 19/09/1997
FDA Releases Draft 510(k) Paradigm for Demonstrating Substantial Equivalence
The FDA is seeking public comments on a new approach to demonstrating substantial equivalence in premarket notifications, aiming to conserve review resources while introducing safe devices into the market.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →